Pegasus Mercantile Inc. (U040)

Overview

Xtacy Therapeutics Corp., previously known as Global Wellness Strategies Inc., operates as an incubator, venture capital, and accelerator firm with a primary focus on the development and financial support of companies in the health and wellness sectors. Founded in 1998 and based in Vancouver, Canada, the firm is recognized for its keen interest in investing in the public and private sectors, particularly those engaged in preventative health, wellness, biotechnology, pain management, psychedelic research, depression, mental health, and medicine. Xtacy Therapeutics is committed to pioneering research and investment in innovative techniques such as micro-dosing with organic compounds and synthetic molecules. Through these ventures, the firm endeavors to offer superior wellness benefits, aiming for solutions that are not only more effective but also safer and more environmentally friendly. The company holds a distinctive position in the market for its contribution to groundbreaking health solutions, supporting both people and the planet.

Products and Services

• Incubation and Startup Support

  This service focuses on nurturing new companies within the health and wellness sectors, providing them with the necessary resources, guidance, and financial support to grow from an idea to a successful enterprise. Xtacy Therapeutics' incubation program is designed to identify and foster innovative business models with the potential to make significant impacts in the health industry.

• Venture Capital and Acceleration Programs

  Xtacy Therapeutics invests in emerging companies showing promise in preventative health, wellness, pain management, mental health, and medicine. The firm's venture capital and acceleration programs offer not only financial investment but also strategic support to help these companies scale quickly and efficiently.

• Investment in Micro-dosing Research

  The firm is at the forefront of researching the effects and benefits of micro-dosing with organic compounds and synthetic molecules. This innovative area of investment aims to develop new, less harmful ways of medication and treatment for various medical conditions, focusing on mental health and pain management without the common side effects associated with many current treatments.

• Debt Financing Facility

  Xtacy Therapeutics offers debt financing options to companies within its investment portfolio. This financial service provides firms the capital they need to expand operations, enter new markets, or enhance product development, ensuring they have the resources needed for continuous growth and development.